These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Chromosome translocation and c-MYC activation by Epstein-Barr virus and Euphorbia tirucalli in B lymphocytes. Aya T; Kinoshita T; Imai S; Koizumi S; Mizuno F; Osato T; Satoh C; Oikawa T; Kuzumaki N; Ohigashi H Lancet; 1991 May; 337(8751):1190. PubMed ID: 1673740 [TBL] [Abstract][Full Text] [Related]
6. Burkitt lymphoma: the role of Epstein-Barr virus revisited. Grömminger S; Mautner J; Bornkamm GW Br J Haematol; 2012 Mar; 156(6):719-29. PubMed ID: 22482131 [No Abstract] [Full Text] [Related]
7. Three restricted forms of Epstein-Barr virus latency counteracting apoptosis in c-myc-expressing Burkitt lymphoma cells. Kelly GL; Milner AE; Baldwin GS; Bell AI; Rickinson AB Proc Natl Acad Sci U S A; 2006 Oct; 103(40):14935-40. PubMed ID: 17001014 [TBL] [Abstract][Full Text] [Related]
8. Epstein-Barr virus reactivation induces MYC-IGH spatial proximity and t(8;14) in B cells. Sall FB; Shmakova A; Karpukhina A; Tsfasman T; Lomov N; Canoy RJ; Boutboul D; Oksenhendler E; Toure AO; Lipinski M; Wiels J; Germini D; Vassetzky Y J Med Virol; 2023 Mar; 95(3):e28633. PubMed ID: 36866703 [TBL] [Abstract][Full Text] [Related]
9. Molecular resemblance of an AIDS-associated lymphoma and endemic Burkitt lymphomas: implications for their pathogenesis. Haluska FG; Russo G; Kant J; Andreef M; Croce CM Proc Natl Acad Sci U S A; 1989 Nov; 86(22):8907-11. PubMed ID: 2682665 [TBL] [Abstract][Full Text] [Related]
10. Burkitt lymphoma--a stalking horse for cancer research? Klein G Semin Cancer Biol; 2009 Dec; 19(6):347-50. PubMed ID: 19607918 [TBL] [Abstract][Full Text] [Related]
11. Epstein-Barr virus and the pathogenesis of Burkitt's lymphoma: more questions than answers. Bornkamm GW Int J Cancer; 2009 Apr; 124(8):1745-55. PubMed ID: 19165855 [TBL] [Abstract][Full Text] [Related]
12. Epstein-Barr virus-associated Burkitt lymphomagenesis selects for downregulation of the nuclear antigen EBNA2. Kelly G; Bell A; Rickinson A Nat Med; 2002 Oct; 8(10):1098-104. PubMed ID: 12219084 [TBL] [Abstract][Full Text] [Related]
13. How does Epstein-Barr virus (EBV) complement the activation of Myc in the pathogenesis of Burkitt's lymphoma? Allday MJ Semin Cancer Biol; 2009 Dec; 19(6):366-76. PubMed ID: 19635566 [TBL] [Abstract][Full Text] [Related]
14. Burkitt lymphoma: revisiting the pathogenesis of a virus-associated malignancy. Kelly GL; Rickinson AB Hematology Am Soc Hematol Educ Program; 2007; ():277-84. PubMed ID: 18024641 [TBL] [Abstract][Full Text] [Related]
15. l-Asparaginase synergizes with etoposide via the PI3K/Akt/mTOR pathway in Epstein-Barr virus-positive Burkitt lymphoma. Sang W; Tu D; Zhang M; Qin Y; Yin W; Song X; Sun C; Yan D; Wang X; Zeng L; Li Z; Xu K; Xu L J Biochem Mol Toxicol; 2022 Aug; 36(8):e23117. PubMed ID: 35757978 [TBL] [Abstract][Full Text] [Related]
16. To the genesis of Burkitt lymphoma: regulation of apoptosis by EBNA-1 and SAP may determine the fate of Ig-myc translocation carrying B lymphocytes. Nagy N; Klein G; Klein E Semin Cancer Biol; 2009 Dec; 19(6):407-10. PubMed ID: 19874894 [TBL] [Abstract][Full Text] [Related]
17. Epstein-Barr virus, the TCL-1 oncogene and Burkitt's lymphoma. Bell A; Rickinson AB Trends Microbiol; 2003 Nov; 11(11):495-7. PubMed ID: 14607063 [TBL] [Abstract][Full Text] [Related]